[1]
“Exploring the Impact of Dapagliflozin on Shock Therapy in Heart Failure Patients with Implantable Cardioverter Defibrillators: A Retrospective Cohort Study”, ccm, vol. 8, no. 2, pp. 159–166, Apr. 2024, Accessed: Sep. 18, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16479